SCHEMBL7219704

SCHEMBL7219704

Cc1cc(C(=O)N(F)C(=NF)NF)ccc1F

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 1/20 0.36
PIM1 P11309 1/20 0.36
MAOA P21397 1/20 0.35
MAOB P27338 1/20 0.35
HDAC1 Q13547 2/20 0.35
HDAC6 Q9UBN7 2/20 0.35
MTOR P42345 1/20 0.33
ALDH1A1 P00352 1/20 0.32
HSD17B10 Q99714 1/20 0.32
DRD4 P21917 1/20 0.31
KDM4E B2RXH2 1/20 0.31
POLB P06746 1/20 0.31
KMT2A Q03164 1/20 0.31
HDAC3 O15379 1/20 0.31
HDAC2 Q92769 1/20 0.31
CES2 O00748 1/20 0.31
CES1 P23141 1/20 0.31
MMP13 P45452 1/20 0.31
IDO1 P14902 1/20 0.31
GRIK2 Q13002 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL91409 0.72 ERN1 (0.49) MAPK14PIM1MAOAMAOBHDAC1
SCHEMBL8074979 0.72 LPAR1 (0.41)
SCHEMBL15998655 0.71 MAOA (0.45) MAPK14PIM1MAOAMAOBHDAC1
SCHEMBL4355959 0.68 SMN1; SMN2 (0.53) PIM1MAOAMAOBHDAC1HDAC6
SCHEMBL4568350 0.67 MLYCD (0.49) MAPK14PIM1MAOAMAOBHDAC1
SCHEMBL1924482 0.66 PIM1 (0.47) PIM1MAOAMAOBHDAC1HDAC6
SCHEMBL385343 0.66 LMNA (0.53) PIM1MAOAMAOBHDAC1HDAC6
SCHEMBL29602493 0.66 PIM1 (0.47) PIM1MAOAMAOBHDAC1HDAC6
SCHEMBL30102019 0.65 HDAC6 (0.53) PIM1HDAC1HDAC6DRD4HDAC2
SCHEMBL1507188 0.65 HDAC6 (0.53) PIM1HDAC1HDAC6DRD4HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6632840-B1 Inhibiting the Na+/H+ exchanger, treating at least one of arrhythmias and shock HOECHST AKTIENGESELLSCHAFT (DE) 2003-10-14 US disclosed
US-6436999-B1 REACTING GUANIDINE AND CARBOCYCLIC ACIDS, TO FORM COMPOUNDS LIKE BIS(3-METHYLSULFONYL-4-I-PROPYLBENZOYL)GUANIDINE, USED FOR PROPHYLAXIS OF CARDIOVASCULAR DISORDERS AND AS PRODRUGS FOR SODIUM CHANNEL MODULATORS TO CONTROL BLOOD PRESSURE HOECHST AKTIENGESELLSCHAFT (DE) 2002-08-20 US disclosed